Literature DB >> 12297326

Poxvirus immune modulators: functional insights from animal models.

Peter C Turner1, Richard W Moyer.   

Abstract

Poxviruses express several different classes of immune modulators that suppress the host response to infection, including soluble cytokine binding proteins, serpins, chemokine binding proteins, a complement control protein, and members of the semaphorin and Toll/IL-1 receptor families. Biochemical activity of these proteins has been demonstrated by many in vitro studies. Conservation in evolution of poxvirus immune modulators implies that these genes are functional in vivo, but the results of infecting animals with knockout viruses have not always been clear cut. Studies involving different animal models are reviewed, and the criteria for suitable models are discussed. Challenges include finding an appropriate animal host, and using an inoculation route that resembles the process of natural infection. The fact that multiple immune modulators can target the same pathway at different steps may explain why single knockout mutants are not always attenuated in animals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297326     DOI: 10.1016/s0168-1702(02)00119-3

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  16 in total

Review 1.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins.

Authors:  Jeffrey O Langland; John C Kash; Victoria Carter; Matthew J Thomas; Michael G Katze; Bertram L Jacobs
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Genome of deerpox virus.

Authors:  C L Afonso; G Delhon; E R Tulman; Z Lu; A Zsak; V M Becerra; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

5.  Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement.

Authors:  Elizabeth A Moulton; Paula Bertram; Nanhai Chen; R Mark L Buller; John P Atkinson
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

Review 6.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

7.  Roles of vaccinia virus genes E3L and K3L and host genes PKR and RNase L during intratracheal infection of C57BL/6 mice.

Authors:  Amanda D Rice; Peter C Turner; Jennifer E Embury; Lyle L Moldawer; Henry V Baker; Richard W Moyer
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

8.  A survey of host range genes in poxvirus genomes.

Authors:  Kirsten A Bratke; Aoife McLysaght; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2012-12-23       Impact factor: 3.342

Review 9.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

10.  Comparative genomics of parasitic silkworm microsporidia reveal an association between genome expansion and host adaptation.

Authors:  Guoqing Pan; Jinshan Xu; Tian Li; Qingyou Xia; Shao-Lun Liu; Guojie Zhang; Songgang Li; Chunfeng Li; Handeng Liu; Liu Yang; Tie Liu; Xi Zhang; Zhengli Wu; Wei Fan; Xiaoqun Dang; Heng Xiang; Meilin Tao; Yanhong Li; Junhua Hu; Zhi Li; Lipeng Lin; Jie Luo; Lina Geng; LinLing Wang; Mengxian Long; Yongji Wan; Ningjia He; Ze Zhang; Cheng Lu; Patrick J Keeling; Jun Wang; Zhonghuai Xiang; Zeyang Zhou
Journal:  BMC Genomics       Date:  2013-03-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.